ESC 2019: Registry study supports use of ICDs for primary prevention in patients with...
New data from the Swedish Heart Failure Registry indicate the use of an implantable cardioverter defibrillator (ICD) in patients with heart failure with reduced...
ESC 2019: Catheter ablation may be up to 10 times more effective than drug...
Results from the Atrial fibrillation progression trial (ATTEST) were presented on 31 August at the European Society of Cardiology (ESC) Congress 2019 in Paris,...
ESC 2019: Left atrial appendage closure is non-inferior to NOACS for preventing neurological events
This morning at the 2019 European Society of Cardiology (ESC) Congress (31 August–4 September, Paris, France), Pavel Osmancik (Charles University and University Hospital Kralovske...
ESC 2019: Study suggests increased use of DOACs in AF leads to lower healthcare...
A four-year Italian study of direct oral anticoagulant (DOAC) use in patients with atrial fibrillation (AF) has shown that as prescription rates increased healthcare...
(Visited 16,370 times, 7 visits today)